| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2018 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 7 | Q2 2024 | 6.9% |
| NOVOCURE LTD | 7 | Q2 2024 | 4.3% |
| BRIDGEBIO PHARMA INC | 7 | Q2 2024 | 5.1% |
| XENON PHARMACEUTICALS INC | 7 | Q2 2024 | 3.1% |
| VAXCYTE INC | 7 | Q2 2024 | 3.0% |
| NUVASIVE INC | 7 | Q2 2024 | 3.5% |
| ALPHATEC HLDGS INC | 7 | Q2 2024 | 3.6% |
| GLAUKOS CORP | 7 | Q2 2024 | 3.0% |
| ALIGN TECHNOLOGY INC | 7 | Q2 2024 | 2.6% |
| IRHYTHM TECHNOLOGIES INC | 7 | Q2 2024 | 2.2% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.